Loading…

Substituent Effects on Desferrithiocin and Desferrithiocin Analogue Iron-Clearing and Toxicity Profiles

Desferrithiocin (DFT, 1) is a very efficient iron chelator when given orally. However, it is severely nephrotoxic. Structure–activity studies with 1 demonstrated that removal of the aromatic nitrogen to provide desazadesferrithiocin (DADFT, 2) and introduction of either a hydroxyl group or a polyeth...

Full description

Saved in:
Bibliographic Details
Published in:Journal of medicinal chemistry 2012-08, Vol.55 (16), p.7090-7103
Main Authors: Bergeron, Raymond J, Wiegand, Jan, Bharti, Neelam, McManis, James S
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-a405t-3d44327494d84f8bf1718fb91ffa289dccd7a1351d44eb37dcf93b6953632a6e3
cites cdi_FETCH-LOGICAL-a405t-3d44327494d84f8bf1718fb91ffa289dccd7a1351d44eb37dcf93b6953632a6e3
container_end_page 7103
container_issue 16
container_start_page 7090
container_title Journal of medicinal chemistry
container_volume 55
creator Bergeron, Raymond J
Wiegand, Jan
Bharti, Neelam
McManis, James S
description Desferrithiocin (DFT, 1) is a very efficient iron chelator when given orally. However, it is severely nephrotoxic. Structure–activity studies with 1 demonstrated that removal of the aromatic nitrogen to provide desazadesferrithiocin (DADFT, 2) and introduction of either a hydroxyl group or a polyether fragment onto the aromatic ring resulted in orally active iron chelators that were much less toxic than 1. The purpose of the current study was to determine if a comparable reduction in renal toxicity could be achieved by performing the same structural manipulations on 1 itself. Accordingly, three DFT analogues were synthesized. The iron-clearing efficiency and ferrokinetics were evaluated in rats and primates; toxicity assessments were carried out in rodents. The resulting DFT ligands demonstrated a reduction in toxicity that was equivalent to that of the DADFT analogues and presented with excellent iron-clearing properties.
doi_str_mv 10.1021/jm300509y
format article
fullrecord <record><control><sourceid>acs_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3583384</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>a624926792</sourcerecordid><originalsourceid>FETCH-LOGICAL-a405t-3d44327494d84f8bf1718fb91ffa289dccd7a1351d44eb37dcf93b6953632a6e3</originalsourceid><addsrcrecordid>eNptkE1Lw0AQhhdRbK0e_AOSiwcP0f1KsrkIpVYtCArW87LZj3RLult2E7H_3mi1KHoamHnmHeYB4BTBSwQxulquCIQZLDd7YIgyDFPKIN0HQwgxTnGOyQAcxbiEEBKEySEYYMxYiQo4BPVzV8XWtp12bTI1Rss2Jt4lNzoaHYJtF9ZL6xLh1J_e2InG151OZsG7dNJoEayrP9G5f7PStpvkKXhjGx2PwYERTdQnX3UEXm6n88l9-vB4N5uMH1JBYdamRFFKcEFLqhg1rDKoQMxUJTJGYFYqKVUhEMlQz-mKFEqaklR5mZGcYJFrMgLX29x1V620kv1bQTR8HexKhA33wvLfE2cXvPavnGSMEEb7gIttgAw-xqDNbhdB_mGb72z37NnPYzvyW28PnG8BISNf-i70xuI_Qe9hg4mu</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Substituent Effects on Desferrithiocin and Desferrithiocin Analogue Iron-Clearing and Toxicity Profiles</title><source>American Chemical Society:Jisc Collections:American Chemical Society Read &amp; Publish Agreement 2022-2024 (Reading list)</source><creator>Bergeron, Raymond J ; Wiegand, Jan ; Bharti, Neelam ; McManis, James S</creator><creatorcontrib>Bergeron, Raymond J ; Wiegand, Jan ; Bharti, Neelam ; McManis, James S</creatorcontrib><description>Desferrithiocin (DFT, 1) is a very efficient iron chelator when given orally. However, it is severely nephrotoxic. Structure–activity studies with 1 demonstrated that removal of the aromatic nitrogen to provide desazadesferrithiocin (DADFT, 2) and introduction of either a hydroxyl group or a polyether fragment onto the aromatic ring resulted in orally active iron chelators that were much less toxic than 1. The purpose of the current study was to determine if a comparable reduction in renal toxicity could be achieved by performing the same structural manipulations on 1 itself. Accordingly, three DFT analogues were synthesized. The iron-clearing efficiency and ferrokinetics were evaluated in rats and primates; toxicity assessments were carried out in rodents. The resulting DFT ligands demonstrated a reduction in toxicity that was equivalent to that of the DADFT analogues and presented with excellent iron-clearing properties.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm300509y</identifier><identifier>PMID: 22889170</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Administration, Oral ; Animals ; Cebus ; Coordination Complexes - chemistry ; Coordination Complexes - metabolism ; Dihydropyridines - chemistry ; Dihydropyridines - metabolism ; Dihydropyridines - pharmacology ; Dihydropyridines - toxicity ; Ethers - chemistry ; Ethers - metabolism ; Ethers - pharmacology ; Ethers - toxicity ; Ferric Compounds - chemistry ; Ferric Compounds - metabolism ; Hydroxylation ; Iron Chelating Agents - chemistry ; Iron Chelating Agents - metabolism ; Iron Chelating Agents - pharmacology ; Iron Chelating Agents - toxicity ; Iron Overload - metabolism ; Kidney - drug effects ; Kidney - physiopathology ; Ligands ; Male ; Rats ; Rats, Sprague-Dawley ; Stereoisomerism ; Structure-Activity Relationship ; Thiazoles - chemistry ; Thiazoles - metabolism ; Thiazoles - pharmacology ; Thiazoles - toxicity</subject><ispartof>Journal of medicinal chemistry, 2012-08, Vol.55 (16), p.7090-7103</ispartof><rights>Copyright © 2012 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a405t-3d44327494d84f8bf1718fb91ffa289dccd7a1351d44eb37dcf93b6953632a6e3</citedby><cites>FETCH-LOGICAL-a405t-3d44327494d84f8bf1718fb91ffa289dccd7a1351d44eb37dcf93b6953632a6e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22889170$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bergeron, Raymond J</creatorcontrib><creatorcontrib>Wiegand, Jan</creatorcontrib><creatorcontrib>Bharti, Neelam</creatorcontrib><creatorcontrib>McManis, James S</creatorcontrib><title>Substituent Effects on Desferrithiocin and Desferrithiocin Analogue Iron-Clearing and Toxicity Profiles</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Desferrithiocin (DFT, 1) is a very efficient iron chelator when given orally. However, it is severely nephrotoxic. Structure–activity studies with 1 demonstrated that removal of the aromatic nitrogen to provide desazadesferrithiocin (DADFT, 2) and introduction of either a hydroxyl group or a polyether fragment onto the aromatic ring resulted in orally active iron chelators that were much less toxic than 1. The purpose of the current study was to determine if a comparable reduction in renal toxicity could be achieved by performing the same structural manipulations on 1 itself. Accordingly, three DFT analogues were synthesized. The iron-clearing efficiency and ferrokinetics were evaluated in rats and primates; toxicity assessments were carried out in rodents. The resulting DFT ligands demonstrated a reduction in toxicity that was equivalent to that of the DADFT analogues and presented with excellent iron-clearing properties.</description><subject>Administration, Oral</subject><subject>Animals</subject><subject>Cebus</subject><subject>Coordination Complexes - chemistry</subject><subject>Coordination Complexes - metabolism</subject><subject>Dihydropyridines - chemistry</subject><subject>Dihydropyridines - metabolism</subject><subject>Dihydropyridines - pharmacology</subject><subject>Dihydropyridines - toxicity</subject><subject>Ethers - chemistry</subject><subject>Ethers - metabolism</subject><subject>Ethers - pharmacology</subject><subject>Ethers - toxicity</subject><subject>Ferric Compounds - chemistry</subject><subject>Ferric Compounds - metabolism</subject><subject>Hydroxylation</subject><subject>Iron Chelating Agents - chemistry</subject><subject>Iron Chelating Agents - metabolism</subject><subject>Iron Chelating Agents - pharmacology</subject><subject>Iron Chelating Agents - toxicity</subject><subject>Iron Overload - metabolism</subject><subject>Kidney - drug effects</subject><subject>Kidney - physiopathology</subject><subject>Ligands</subject><subject>Male</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>Stereoisomerism</subject><subject>Structure-Activity Relationship</subject><subject>Thiazoles - chemistry</subject><subject>Thiazoles - metabolism</subject><subject>Thiazoles - pharmacology</subject><subject>Thiazoles - toxicity</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><recordid>eNptkE1Lw0AQhhdRbK0e_AOSiwcP0f1KsrkIpVYtCArW87LZj3RLult2E7H_3mi1KHoamHnmHeYB4BTBSwQxulquCIQZLDd7YIgyDFPKIN0HQwgxTnGOyQAcxbiEEBKEySEYYMxYiQo4BPVzV8XWtp12bTI1Rss2Jt4lNzoaHYJtF9ZL6xLh1J_e2InG151OZsG7dNJoEayrP9G5f7PStpvkKXhjGx2PwYERTdQnX3UEXm6n88l9-vB4N5uMH1JBYdamRFFKcEFLqhg1rDKoQMxUJTJGYFYqKVUhEMlQz-mKFEqaklR5mZGcYJFrMgLX29x1V620kv1bQTR8HexKhA33wvLfE2cXvPavnGSMEEb7gIttgAw-xqDNbhdB_mGb72z37NnPYzvyW28PnG8BISNf-i70xuI_Qe9hg4mu</recordid><startdate>20120823</startdate><enddate>20120823</enddate><creator>Bergeron, Raymond J</creator><creator>Wiegand, Jan</creator><creator>Bharti, Neelam</creator><creator>McManis, James S</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20120823</creationdate><title>Substituent Effects on Desferrithiocin and Desferrithiocin Analogue Iron-Clearing and Toxicity Profiles</title><author>Bergeron, Raymond J ; Wiegand, Jan ; Bharti, Neelam ; McManis, James S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a405t-3d44327494d84f8bf1718fb91ffa289dccd7a1351d44eb37dcf93b6953632a6e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Administration, Oral</topic><topic>Animals</topic><topic>Cebus</topic><topic>Coordination Complexes - chemistry</topic><topic>Coordination Complexes - metabolism</topic><topic>Dihydropyridines - chemistry</topic><topic>Dihydropyridines - metabolism</topic><topic>Dihydropyridines - pharmacology</topic><topic>Dihydropyridines - toxicity</topic><topic>Ethers - chemistry</topic><topic>Ethers - metabolism</topic><topic>Ethers - pharmacology</topic><topic>Ethers - toxicity</topic><topic>Ferric Compounds - chemistry</topic><topic>Ferric Compounds - metabolism</topic><topic>Hydroxylation</topic><topic>Iron Chelating Agents - chemistry</topic><topic>Iron Chelating Agents - metabolism</topic><topic>Iron Chelating Agents - pharmacology</topic><topic>Iron Chelating Agents - toxicity</topic><topic>Iron Overload - metabolism</topic><topic>Kidney - drug effects</topic><topic>Kidney - physiopathology</topic><topic>Ligands</topic><topic>Male</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>Stereoisomerism</topic><topic>Structure-Activity Relationship</topic><topic>Thiazoles - chemistry</topic><topic>Thiazoles - metabolism</topic><topic>Thiazoles - pharmacology</topic><topic>Thiazoles - toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bergeron, Raymond J</creatorcontrib><creatorcontrib>Wiegand, Jan</creatorcontrib><creatorcontrib>Bharti, Neelam</creatorcontrib><creatorcontrib>McManis, James S</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bergeron, Raymond J</au><au>Wiegand, Jan</au><au>Bharti, Neelam</au><au>McManis, James S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Substituent Effects on Desferrithiocin and Desferrithiocin Analogue Iron-Clearing and Toxicity Profiles</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2012-08-23</date><risdate>2012</risdate><volume>55</volume><issue>16</issue><spage>7090</spage><epage>7103</epage><pages>7090-7103</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>Desferrithiocin (DFT, 1) is a very efficient iron chelator when given orally. However, it is severely nephrotoxic. Structure–activity studies with 1 demonstrated that removal of the aromatic nitrogen to provide desazadesferrithiocin (DADFT, 2) and introduction of either a hydroxyl group or a polyether fragment onto the aromatic ring resulted in orally active iron chelators that were much less toxic than 1. The purpose of the current study was to determine if a comparable reduction in renal toxicity could be achieved by performing the same structural manipulations on 1 itself. Accordingly, three DFT analogues were synthesized. The iron-clearing efficiency and ferrokinetics were evaluated in rats and primates; toxicity assessments were carried out in rodents. The resulting DFT ligands demonstrated a reduction in toxicity that was equivalent to that of the DADFT analogues and presented with excellent iron-clearing properties.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>22889170</pmid><doi>10.1021/jm300509y</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2012-08, Vol.55 (16), p.7090-7103
issn 0022-2623
1520-4804
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3583384
source American Chemical Society:Jisc Collections:American Chemical Society Read & Publish Agreement 2022-2024 (Reading list)
subjects Administration, Oral
Animals
Cebus
Coordination Complexes - chemistry
Coordination Complexes - metabolism
Dihydropyridines - chemistry
Dihydropyridines - metabolism
Dihydropyridines - pharmacology
Dihydropyridines - toxicity
Ethers - chemistry
Ethers - metabolism
Ethers - pharmacology
Ethers - toxicity
Ferric Compounds - chemistry
Ferric Compounds - metabolism
Hydroxylation
Iron Chelating Agents - chemistry
Iron Chelating Agents - metabolism
Iron Chelating Agents - pharmacology
Iron Chelating Agents - toxicity
Iron Overload - metabolism
Kidney - drug effects
Kidney - physiopathology
Ligands
Male
Rats
Rats, Sprague-Dawley
Stereoisomerism
Structure-Activity Relationship
Thiazoles - chemistry
Thiazoles - metabolism
Thiazoles - pharmacology
Thiazoles - toxicity
title Substituent Effects on Desferrithiocin and Desferrithiocin Analogue Iron-Clearing and Toxicity Profiles
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T12%3A36%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-acs_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Substituent%20Effects%20on%20Desferrithiocin%20and%20Desferrithiocin%20Analogue%20Iron-Clearing%20and%20Toxicity%20Profiles&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Bergeron,%20Raymond%20J&rft.date=2012-08-23&rft.volume=55&rft.issue=16&rft.spage=7090&rft.epage=7103&rft.pages=7090-7103&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/jm300509y&rft_dat=%3Cacs_pubme%3Ea624926792%3C/acs_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-a405t-3d44327494d84f8bf1718fb91ffa289dccd7a1351d44eb37dcf93b6953632a6e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/22889170&rfr_iscdi=true